Insider Shareholders with Direct Ownership of Tff Pharmaceuticals, Inc. (TFFP)
This section provides a comprehensive overview of the insiders with direct ownership of Tff Pharmaceuticals, Inc. (TFFP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
TFF Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Lung Therapeutics, Inc.
> 10% Shareholder |
0 | 1,765,000 | 2,235,000 $134,100 | 2 |
Mar 26, 2021
Reduced 24.24%
|
|
Harlan F Weisman
President and CEO |
837,095 | 0 | 842,095 $50,525 | 7 |
Jul 03, 2024
Added 3.16%
|
|
Zamaneh Mikhak
Chief Medical Officer |
145,184 | 0 | 145,184 $8,711 | 3 |
Jul 03, 2024
Added 6.55%
|
|
Aaron G.L. Fletcher
Director |
48,470 | 0 | 143,470 $8,608 | 2 |
Nov 22, 2022
Added 23.25%
|
|
Robert S Mills
Director |
134,359 | 91,194 | 59,145 $3,548 | 10 |
Jul 03, 2024
Added 5.08%
|
|
Kirk Allen Coleman
Chief Financial Officer |
84,859 | 40,000 | 45,859 $2,751 | 16 |
Jul 03, 2024
Added 18.17%
|
|
Stephen Rocamboli
Director |
96,171 | 57,006 | 39,165 $2,349 | 10 |
Jul 03, 2024
Added 7.48%
|
|
Glenn R. Mattes
President and CEO |
294,830 | 268,830 | 36,000 $2,160 | 12 |
May 16, 2022
Added 30.77%
|
|
Brandi Roberts
Director |
23,165 | 0 | 23,165 $1,389 | 2 |
Jul 03, 2024
Added 12.02%
|
|
James Brian Windsor
Chief Science Officer |
25,000 | 25,000 | 5,000 $300 | 2 |
Dec 07, 2020
Reduced 83.33%
|
|
Thomas Braxton King
Director |
1,583 | 0 | 1,583 $94 | 1 |
Jul 03, 2024
Added 50.0%
|
|
Catherine Chai Zon Lee
Director |
1,583 | 0 | 1,583 $94 | 1 |
Jul 03, 2024
Added 50.0%
|
|
Randy H Thurman
Director |
75,809 | 79,759 | 0 $0 | 6 |
Sep 29, 2022
Reduced 100.0%
|